Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer

Authors
Category Primary study
JournalCancer Research
Year 2019
This article has no abstract
Epistemonikos ID: 97c069500495727f64e0d8648f1e73562db8171d
First added on: Feb 11, 2025